Monique G. Davis Do

Monique G. Davis Do

Auto-generated profile, based on publicly available information

Monique G. Davis Do

Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2022 in Infectious Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
RGRoberto Guevara
Roberto Guevara
MDMonique G. Davis
Monique G. Davis
MDMichelle A. Davis
Michelle A. Davis
SASara Ahmed
Sara Ahmed
SSSidra Shah
Sidra Shah
KCKarla Cuaron
Karla Cuaron
Background: Rapid administration of appropriately indicated antibiotics is crucial in septic patients. Sepsis data supports that there is a higher risk of mortality for each hour delay from triage to antibiotic therapy, as well as for inappropriate antibiotic selection. There are a variety of rapid microbial detection systems, such as VERIGENE®, used in acute care facilities to rapidly detect bacteremia and identify resistance markers. Our study investigates the usefulness of VERIGENE® assays in accurately detecting Gram-positive and Gram-negative pathogens when compared to traditional blood culture analysis systems, such as VITEK®. Methods: 819 Gram-positive and 373 Gram-negative blood samples were collected and tested using both VERIGENE® and VITEK®. Statistical tests were two-tailed and observations were defined as statistically significant if P ≤ 0.05. Results: VERIGENE® detected a pathogen in 816/819 (99.6%) samples of the Gram-positive blood cultures and 367/373 (98.3%) samples of the Gram-negatives compared to 805/819 (98.3%) and 367/373 (98.4%), respectively, using VITEK®. Gram-positive cultures had a sensitivity of 99.5% and a specificity of 27.3% (PPV 99.0%, NPV 42.9%, 98.7% accuracy) with VERIGENE analysis. Gramnegatives had a sensitivity of 99.2% and a specificity of 20.0% (PPV 98.9%, NPV 25.0%, 98.4% accuracy). Conclusions: Although statistically insignificant (P = 0.25), VERIGENE® was 1.3% more likely to identify Gram-positive bacteria when compared to conventional methods. Overall, we concluded that VERIGENE® assays are valuable in their ability to rapidly detect microorganisms and resistance markers, given their high sensitivities. This allows for select targeted therapy in patients with sepsis and can ultimately reduce mortality rates.

18 May 2023 in Cardiovascular Drugs and Therapy
Verified
Journal Article
Open access
PDF file
MDMonique G. Davis Do
Monique G. Davis Do
JBJames C Blankenship
James C Blankenship
Keypoints: It is unclear what role, if any, intracoronary thrombolysis plays in the management of ST-segment elevation myocardial infarction (STEMI) with primary percutaneous coronary intervention (PPCI). In this meta-analysis intracoronary thrombolysis-facilitated PPCI for STEMI was associated with improved outcomes compared to standard PPCI. A randomized controlled trial would be necessary to settle the question of whether intracoronary thrombolysis is a useful adjunct to PPCI and whether it is most effective before, during, or after PPCI.